Opioid Alternative Position Topricin as a non-prescription, non-chemical pain relief option that can reduce dependence on opioid and nerve pain medications, appealing to healthcare providers seeking safer analgesic alternatives and to retailers targeting pain management categories.

Clinical Adoption Leverage the company’s B Corp status and clinical reputation to target integrative medicine clinics, physical therapy practices, and dermatology/neurology specialists that value safe, evidence-based topical biomedicines for neuropathy and post-surgical recovery.

Neuropathy Niche Highlight neuropathy and fibromyalgia patent history and demonstrated benefits for chemo-induced and diabetic neuropathy to pursue partnerships with oncologists, endocrinologists, and specialty pharmacies focusing on pain management and quality-of-life improvements.

US-Made Advantage Emphasize domestically produced products and national retail availability to attract distributors and pharmacy chains that prioritize American-made wellness and safety standards, expanding shelf presence in pharmacies and retailers.

Growth Signals Target mid-market wellness retailers and clinics given the revenue range and scalable digital footprint, using the company’s online credentials and educational content to drive co-branded campaigns and patient education programs.